FDA-Drug2026-06-24Class IIMISBRANDING
IntegraDose Vasopressin syringes recalled for subpotent drug content
IntegraDose Vasopressin syringes recalled for subpotency
IntegraDose Compounding Services LLC is recalling Vasopressin 2 Units/2 mL syringes because the drug may contain less active ingredient than labeled. This affects two specific lots distributed nationwide. No injuries have been reported.
- Check if you have syringes from lot 20260327VAS-3 (expires 05/26/2026) or lot 20260320VAS-3 (expires 05/19/2026).
- Contact your pharmacy or healthcare provider if you have received these syringes.
- Do not use the recalled syringes without consulting your provider.
Hazard
Subpotent Drug
Who it affects
Adults
Illnesses reported
None reported
Sold states
U.S.A. Nationwide
Affected count
287 units
Manufactured in
3650 Victoria St N Ste 900, Shoreview, MN, United States
Products
Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, IntegraDose Compounding Services, LLC. 3650 Victoria St N, Suite 900, Shoreview, MN, NDC 71139-0190-1.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0593-2026More IntegraDose recalls
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief